Artificial intelligence is moving deeper into medicine, and two recent reports capture both its potential and its pitfalls.
On the administrative side, the picture is rocky. According to CBS News, Medicare's push to use AI has "snarled" patients and doctors in errors and delays. The headline points to a system where automation, intended to streamline care, is instead introducing mistakes and slowdowns into the experience of people seeking treatment and the clinicians trying to provide it.
The research front looks more encouraging. According to Vanderbilt Health News, scientists have developed a new framework designed to make AI "trustworthy" for cancer subtyping — the process of distinguishing between different forms of a cancer, which can shape how a patient is treated. The emphasis on trustworthiness is notable: a recurring concern with medical AI is that systems can produce confident answers without a clear basis for clinicians to rely on them.
Together, the two reports sketch a familiar pattern in health technology. In controlled research settings, where the goal is accuracy and reliability, new methods can make AI more dependable. But when AI is deployed at scale across real-world systems like Medicare, the same technology can create friction, errors, and delays that affect ordinary patients.
The gap between these two stories is the heart of the issue. Building an AI tool that performs well on a specific medical task is different from rolling AI into a sprawling healthcare bureaucracy that millions depend on.
Why it matters: As AI spreads through both medical research and the systems that decide and deliver care, whether it helps or harms patients will hinge on how carefully — and how transparently — it is built and deployed.